Intravenous tocilizumab in the treatment of resistant optic perineuritis. Maleki A, Ramezani K, Colombo A, Foster CS, et al. Can J Ophthalmol 2022;57:e100-e103.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Maleki A, Ramezani K, Colombo A, Foster CS, et al. Intravenous tocilizumab in the treatment of resistant optic perineuritis. Can J Ophthalmol 2022;57:e100-e103.
PMID: 34742701